Procurement Summary
Country : Chile
Summary : Perutuzumab Bevacizumab Metotrexate and Azacitidine Agreement
Deadline : 28 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117849639
Document Ref. No. : 5051-29-LP25
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The objective of this tender is to invite through www.mercadopublica.cl to all the suppliers of the item to participate in the acquisition of Pertuzumab, Bevacizumab, Metrexate and Azacitidine, necessary for direct care for clinical patients in the services of the Regional Hospital ofTalca and under the technical specifications required by the institution in order to select the most convenient offer according to the evaluation criteria, ensuring the supply in quality and opportunity, thus satisfying the demand of the users for an 18 -month period.
Productso Services: Alemtuzumab, Metotrexate, Daclizumab, Medicine or Medicine Production Services
Documents
Tender Notice